Elena Dulaeva

Elena Dulaeva

Auto-generated profile, based on publicly available information

Elena Dulaeva

V.I. Krasnopolsky Moscow Regional Research Institute of Obstetrics and Gynecology

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2023 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
EEE.B. Efimkova
E.B. Efimkova
SNS.V. Novikova
S.V. Novikova
EDE.V. Dulaeva
E.V. Dulaeva
MCM.A. Chechneva
M.A. Chechneva
TBT.S. Budykina
T.S. Budykina
AYA.A. Yakubina
A.A. Yakubina
Objective. To improve perinatal outcomes in pregnant women with a new coronavirus infection COVID-19 by optimizing diagnostic, therapeutic, and prophylactic measures. Material and methods. The course of pregnancy, labor and perinatal outcomes were studied in 70 patients with COVID-19 during the present pregnancy who were delivered at the Moscow Regional Research Institute of Obstetrics and Gynecology (MORRIOG). The patients were divided into 2 groups depending on the timing of their visit to the outpatient department of MORRIOG: Group 1 comprised 45 pregnant women with new-onset coronavirus infection in the first to second trimesters of gestation, with subsequent presentation and follow-up at the MORRIOG outpatient department; Group 2 comprised 25 pregnant women who had new-onset coronavirus (NCD) infection during gestation and presented to the outpatient department before delivery. In addition to a general clinical examination, all pregnant women underwent an extended haemostatic analysis, including a thrombodynamic test. Results. Analysis of the findings showed that hypercoagulable changes in the hemostatic system were observed in pregnant women with COVID-19 infection during gestation, but standard hemostatic tests did not reflect the characteristic postinfectional changes compared with the results of an extended coagulation potential study using the thrombodynamics test. Hypercoagulative changes were revealed irrespective of the severity of the COVID-19, which could be due to the combination of several risk factors and the presence of concomitant extragenital diseases. Conclusion. The most favorable gestational outcome in patients who have suffered a COVID-19 infection during pregnancy depends on the timely of the detection of hemostasis abnormalities after comprehensive examination and on the composition of available pathogenetic therapy. Rational anticoagulant and antiplatelet therapy under control of the coagulation parameters and achievement of normalization of coagulation tests result in a significant reduction in adverse obstetric and perinatal outcomes.

14 April 2023 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
AYA.A. Yakubina
A.A. Yakubina
AAA.N. Aksenov
A.N. Aksenov
IBI.I. Bocharova
I.I. Bocharova
MTM.V. Troitskaya
M.V. Troitskaya
MBM.YU. Bukina
M.YU. Bukina
EDE.V. Dulaeva
E.V. Dulaeva
A review of the literature is devoted to the information on the effect of a new coronavirus infection (COVID-19) on the course of pregnancy, the possibility of vertical transmission of the virus from mother to fetus and the condition of the neonates. A review of the literature reveals similarities in the clinical manifestations of COVID-19 in pregnant and non-pregnant women. However, pregnant women are reported to have an increased risk of ICU admission and need for ventilatory support in various countries. Transplacental transmission from the mother to the fetus has been widely reported. Preterm birth is now common among pregnancy outcomes, especially in women who have had moderate to severe COVID-19. In the assessment of newborns born to mothers with COVID-19, prematurity, hypoxic conditions and respiratory disorders predominated. Further study of the pathogenesis of a new coronavirus infection is necessary to determine factors of possible vertical transmission, the effect on fetal growth and development, the course of pregnancy and labor, and peculiarities of the early neonatal period in infants whose mothers had had this infection in the first and second trimesters of pregnancy.

30 January 2024 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
EEE.B. Efimkova
E.B. Efimkova
SNS.V. Novikova
S.V. Novikova
EDE.V. Dulaeva
E.V. Dulaeva
MIM.A. Ignat’eVa
M.A. Ignat’eVa
NBN.V. Biryukova
N.V. Biryukova
EPE.V. Pel’sHe
E.V. Pel’sHe
Objective. To analyze obstetric and perinatal outcomes in pregnant women with concomitant respiratory diseases who had acute respiratory infections during gestation. Material and methods. Sixty pregnant women with bronchial asthma of moderately severe course with acute respiratory infection during gestation were examined and delivered. Retrospectively, they were divided into two groups of 30 patients each: Group 1 consisted of patients who had an acute respiratory infection before 16 weeks of gestation, and Group 2 included pregnant women who became ill at 16—30 weeks of gestation. The comparison group (group 3) consisted of 20 pregnant women with bronchial asthma without acute inflammatory diseases during gestation. General clinical examination, extended study of the hemostasis system, hormones of fetoplacental complex and interferon status, acid-base state of capillary blood, saturation, ultrasound and Doppler parameters in dynamics were investigated. Results. It was shown that exacerbation of bronchial asthma during pregnancy was significantly more frequent in the main groups: group 1 — in 70%, group 2 — in 53.3%, group 3 — in 30%. This correlated with the frequency of obstetric and perinatal complications. In Group 1, the Apgar score at birth in 43.3% of newborns was less than 8 points, which was 2.6 times more frequent than in Group 2. Fetal growth retardation in group 1 was diagnosed in 30% of children, which was probably associated with the formation of PI of infectious genesis at an earlier gestational age than in group 2. Conclusion. The obtained results indicate a negative effect of acute respiratory infection on the course of pregnancy in patients with respiratory diseases regardless of the severity of acute respiratory infection. This requires clarification of pathogenetic mechanisms of development of these complications and optimization of management of this contingent of patients.

1 January 2023 in Doctor.Ru
Verified
Journal Article
Open access
EEE.B. Efimkova
E.B. Efimkova
MGMoscow Regional Research Institute of Obstetrics and Gynecology
Moscow Regional Research Institute of Obstetrics and Gynecology
EDE.V. Dulaeva
E.V. Dulaeva
MCM.A. Chechneva
M.A. Chechneva
TBT.S. Budykina
T.S. Budykina
RMRussian Federation Moscow
Russian Federation Moscow
Aim: The aim of the study was to optimize diagnostic, treatment and preventive measures in pregnant women who had a new coronavirus infection (NCI) COVID-19 during the gestation period. Design: Comparative study. Materials and methods. We studied the course of pregnancy, childbirth and perinatal outcomes in 60 women who had COVID-19 during this pregnancy, delivered in the conditions of the MONIAH. Patients were divided into two groups depending on the period of visit to the outpatient department of MORIAG. Group I consisted of 45 pregnant women who underwent NCI in the I–II trimesters with subsequent treatment and observation in the conditions of the polyclinic department of MONIAH, Group II — 15 pregnant women who had had NCI during gestation and applied to the polyclinic department before delivery. In the course of the work, in addition to the general clinical examination, an extended study of the hemostasis system was additionally carried out (during registration, before delivery and according to indications in order to control ongoing therapy), ultrasound and Doppler studies in dynamics, analysis of gestational and perinatal outcomes, the timing of the disease and course of the NCI. Results. During the first consultation, all participants in the study underwent ultrasound and an analysis of standard hemostasiological tests was performed. In pregnant women who received low molecular weight heparins, as well as in cases of placental insufficiency and/or structural changes in the placenta, thrombodynamics was studied (n = 21). Women of group II had a significantly lower APTT, a higher level of prothrombin in the blood, and they also had statistically significantly more signs of hemodynamic disturbances in the BMD. According to ultrasound findings, uteroplacental blood flow disorders were diagnosed in 13 patients; thrombodynamics test results demonstrate hypercoagulation in 17 women, while the data from the routine assessment of hemostasis did not go beyond the reference values. Structural changes in the placenta were found in 8 (53.4%) examined patients of group II, and a thrombodynamic test was performed in 5 of them. Hypercoagulation was detected in 4 (26.7%) patients in group II. In patients of group I, depending on the results obtained, correction of therapy was carried out, followed by ultrasound control of the structure of the placenta, as well as an assessment of the thrombodynamic test. Conclusion. Women who have undergone NCI during gestation, regardless of the clinical course and duration of infection with NCI, are characterized by hypercoagulable changes, however, standard hemostasiological tests do not fully reflect post-covid changes, in contrast to the thrombodynamic test in combination with careful placentometry, in which structural changes in the placenta and violations of intraplacental blood flow may indirectly indicate the presence of hypercoagulability. Rational anticoagulant and antiplatelet therapy under the control of indicators of the blood coagulation system and the structure of the placenta contributes to a significant reduction in the incidence of adverse obstetric and perinatal outcomes. Keywords: new coronavirus infection, pregnancy, placental insufficiency, doplerometry, thrombodynamic test.

11 March 2024 in Universum:Medicine & Pharmacology
Verified
Journal Article
Open access
EEEkaterina Efimkova
Ekaterina Efimkova
EDElena Dulayeva
Elena Dulayeva
AYAnna Yakubina
Anna Yakubina
IKInna Klimova
Inna Klimova
ОРИ ВО ВРЕМЯ ГЕСТАЦИИ У ПАЦИЕНТОК, ПЕРЕНЕСШИХ COVID-19 ДО НАСТУПЛЕНИЯ БЕРЕМЕННОСТИ И В РАННИЕ СРОКИ ГЕСТАЦИИ: СОСТОЯНИЕ МУКОЗАЛЬНОГО И ПРОТИВОИНФЕКЦИОННОГО ИММУНИТЕТА // Universum: медицина и фармакология : электрон. научн. журн. Ефимкова Е.Б. [и др.]. 2024. 3(108). URL: https://7universum.com/ru/med/archive/item/16984

30 November 2021 in Медицинский оппонент
Verified
Journal Article
Closed access
ЕЕЕ.б. Ефимкова
Е.б. Ефимкова
СНС.в. Новикова
С.в. Новикова
ЕДЕ.в. Дулаева
Е.в. Дулаева
ИБИ.и. Бочарова
И.и. Бочарова